AIG
IDXG

American International Group’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

American International Group’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-69
Closed -$32.4K – 4797
2013
Q2 		$32.4K Buy
+69
New +$31.3K ﹤0.01% 3758

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
LCM
Leonard Capital Management Vero Beach, Florida $5.25M AUM

American International Group's IDXG Position: Q3 2013 in Review

American International Group sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q3 2013, closing a stake of 69 shares — an estimated $32.4K sold.

American International Group first reported a position in IDXG in Q2 2013 and held it in 1 quarter. The position peaked at $32.4K in Q2 2013. 29 funds tracked by Wall St. Rank hold IDXG as of Q3 2013.

  • American International Group reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • American International Group sold 69 Interpace Biosciences, Inc. Common Stock shares in Q3 2013, an estimated $32.4K.
  • American International Group first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • American International Group's Interpace Biosciences, Inc. Common Stock position peaked at $32.4K in Q2 2013.
  • 29 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q3 2013.

Based on American International Group's 13F filing for Q3 2013, filed 7 Nov 2013.